Amgen has increased its quarterly dividend from $0.28 in 2011 to $2.52 in 2026, representing an 800% growth over 15 years. The company’s dividend raises have slowed recently but remain supported by strong cash flow and reduced share count. With dividends covered well by free cash flow and debt declining, Amgen is expected to continue mid-single-digit dividend increases, signaling confidence in its financial health despite challenges like patent cliffs and drug price controls.
As of Nov 08, 2026 21:21 WIB, Amgen's stock (AMGN) trades at USD 460.42 on Pluang with a slight 1-day increase of 0.03%. The company's market capitalization stands at $249.05 billion, reflecting its significant presence in the health sector. Notably, Amgen offers a dividend yield of 2.19%, underscoring its ongoing commitment to shareholder returns.
